American International Group, Inc. Syndax Pharmaceuticals Inc Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$19.71 - $24.57 $110,592 - $137,862	5,611 Added 16.89%	38,832 $924,000
Q4 2023 Feb 13, 2024	BUY	$11.39 - $21.67 $3,872 - $7,367	340 Added 1.03%	33,221 $717,000
Q3 2023 Nov 13, 2023	BUY	$14.52 - $21.77 $16,973 - $25,449	1,169 Added 3.69%	32,881 $477,000
Q2 2023 Aug 04, 2023	BUY	$19.35 - $22.31 $51,722 - $59,634	2,673 Added 9.2%	31,712 $663,000
Q1 2023 May 12, 2023	BUY	$20.66 - $28.98 $79,974 - $112,181	3,871 Added 15.38%	29,039 $613,000
Q4 2022 Feb 10, 2023	SELL	$20.64 - $26.24 $1,919 - $2,440	-93 Reduced 0.37%	25,168 $640,000
Q3 2022 Nov 14, 2022	BUY	$18.51 - $24.79 $19,250 - $25,781	1,040 Added 4.29%	25,261 $607,000
Q2 2022 Aug 12, 2022	SELL	$13.64 - $19.48 $2,018 - $2,883	-148 Reduced 0.61%	24,221 $466,000
Q1 2022 May 13, 2022	BUY	$14.84 - $22.15 $7,019 - $10,476	473 Added 1.98%	24,369 $424,000
Q4 2021 Feb 11, 2022	SELL	$15.23 - $22.47 $10,874 - $16,043	-714 Reduced 2.9%	23,896 $523,000
Q3 2021 Nov 12, 2021	SELL	$13.87 - $19.8 $8,127 - $11,602	-586 Reduced 2.33%	24,610 $470,000
Q2 2021 Aug 13, 2021	BUY	$13.42 - $25.18 $94,879 - $178,022	7,070 Added 39.0%	25,196 $433,000
Q1 2021 May 07, 2021	BUY	$19.28 - $24.59 $47,583 - $60,688	2,468 Added 15.76%	18,126 $405,000
Q4 2020 Feb 12, 2021	SELL	$15.1 - $26.44 $6,779 - $11,871	-449 Reduced 2.79%	15,658 $348,000
Q3 2020 Nov 04, 2020	SELL	$13.39 - $17.48 $4,914 - $6,415	-367 Reduced 2.23%	16,107 $238,000
Q2 2020 Aug 12, 2020	BUY	$8.94 - $20.98 $28,795 - $67,576	3,221 Added 24.3%	16,474 $244,000
Q1 2020 May 04, 2020	BUY	$6.65 - $12.03 $4,428 - $8,011	666 Added 5.29%	13,253 $145,000
Q4 2019 Feb 05, 2020	SELL	$5.43 - $9.22 $581 - $986	-107 Reduced 0.84%	12,587 $111,000
Q3 2019 Nov 08, 2019	SELL	$7.47 - $10.76 $657 - $946	-88 Reduced 0.69%	12,694 $95,000
Q2 2019 Aug 13, 2019	BUY	$4.9 - $9.31 $16,067 - $30,527	3,279 Added 34.5%	12,782 $119,000
Q1 2019 May 06, 2019	BUY	$4.26 - $6.86 $1,180 - $1,900	277 Added 3.0%	9,503 $50,000
Q4 2018 Feb 13, 2019	SELL	$3.6 - $8.42 $255 - $597	-71 Reduced 0.76%	9,226 $41,000
Q3 2018 Nov 09, 2018	SELL	$6.33 - $8.08 $2,285 - $2,916	-361 Reduced 3.74%	9,297 $75,000
Q2 2018 Aug 08, 2018	BUY	$6.93 - $14.63 $14,767 - $31,176	2,131 Added 28.31%	9,658 $68,000
Q1 2018 May 07, 2018	SELL	$8.71 - $14.82 $3,518 - $5,987	-404 Reduced 5.09%	7,527 $107,000
Q4 2017 Feb 09, 2018	BUY	$7.8 - $12.94 $15,779 - $26,177	2,023 Added 34.24%	7,931 $69,000
Q3 2017 Nov 09, 2017	BUY	$10.9 - $12.73 $64,397 - $75,208	5,908	5,908 $69,000

Others Institutions Holding SNDX

# of Institutions

227

Shares Held

88.3M

Call Options Held

1.01M

Put Options Held

692K

Black Rock Inc. New York, NY

7.91M
Shares

$127 Million
0.0% of portfolio
Kynam Capital Management, LP Princeton, NJ

5.84M
Shares

$94 Million
9.23% of portfolio
Wellington Management Group LLP Boston, MA

4.99M
Shares

$80.2 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

4.89M
Shares

$78.6 Million
0.0% of portfolio
Eversept Partners, LP New York, NY

4.11M
Shares

$66.1 Million
6.25% of portfolio

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $910M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account